Published in Am J Med on January 01, 1977
Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A (1993) 5.39
An overview of anthrax infection including the recently identified form of disease in injection drug users. Intensive Care Med (2012) 2.10
Bacillus anthracis. J Clin Pathol (2003) 1.82
Anthrax of the gastrointestinal tract. Emerg Infect Dis (2002) 1.24
Death at Sverdlovsk: what have we learned? Am J Pathol (1994) 0.96
Bacillus anthracis as an agent of bioterrorism: a review emphasizing surgical treatment. Ann Surg (2002) 0.85
Antimicrobial Treatment for Systemic Anthrax: Analysis of Cases from 1945 to 2014 Identified Through a Systematic Literature Review. Health Secur (2015) 0.81
Endemic gastrointestinal anthrax in 1960s Lebanon: clinical manifestations and surgical findings. Emerg Infect Dis (2003) 0.80
Anthrax of the gastrointestinal tract and oropharynx: CT findings. Emerg Radiol (2009) 0.76
Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet (1978) 10.29
Vibrio cholerae enterotoxin and its mode of action. Bacteriol Rev (1971) 4.98
Duration of infection-derived immunity to cholera. J Infect Dis (1981) 3.60
Rapid recognition of group-B Streptococci. Lancet (1977) 3.42
Effect of cholera enterotoxin on ion transport across isolated ileal mucosa. J Clin Invest (1972) 3.28
Deactivation of cholera toxin by ganglioside. J Infect Dis (1971) 3.16
Adsorption and growth of Vibrio cholerae on chitin. Infect Immun (1979) 2.90
Antibiotic therapy of cholera. Bull World Health Organ (1967) 2.73
Failure of sanitary wells to protect against cholera and other diarrhoeas in Bangladesh. Lancet (1976) 2.64
Rise in childhood obesity with persistently high rates of undernutrition among urban school-aged Indo-Asian children. Arch Dis Child (2007) 2.57
Hafnia alvei, a probable cause of diarrhea in humans. Infect Immun (1991) 2.55
Oral maintenance therapy for cholera in adults. Lancet (1968) 2.53
Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity. Trans R Soc Trop Med Hyg (1979) 2.51
Type 2 diabetes in rural and urban population: diverse prevalence and associated risk factors in Bangladesh. Diabet Med (2005) 2.45
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. Infect Immun (1980) 2.42
Effects of prostaglandins, theophylline, and cholera exotoxin upon transmucosal water and electrolyte movement in the canine jejunum. Gastroenterology (1971) 2.39
Basic principles for use of dental cone beam computed tomography: consensus guidelines of the European Academy of Dental and Maxillofacial Radiology. Dentomaxillofac Radiol (2009) 2.38
Stimulation of glycerol production in fat cells by cholera toxin. Nature (1970) 2.34
Immunity to enterotoxigenic Escherichia coli. Infect Immun (1979) 2.30
The pathogenicity of nonenterotoxigenic Vibrio cholerae serogroup O1 biotype El Tor isolated from sewage water in Brazil. J Infect Dis (1982) 2.13
Letter: Febrile reactions after methicillin. Lancet (1974) 2.09
Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity. Further evidence for the role of cyclic adenosine 3',5'-monophosphate. J Clin Invest (1973) 1.94
Is Clostridium difficile endemic in chronic-care facilities? Lancet (1986) 1.88
Rice-powder electrolyte solution as oral-therapy in diarrhoea due to Vibrio cholerae and Escherichia coli. Lancet (1982) 1.87
Can vitamin D deficiency produce an unusual pain syndrome? Arch Intern Med (1991) 1.80
Health care risk factors among women and personal behaviours among men explain the high prevalence of hepatitis C virus infection in Karachi, Pakistan. J Viral Hepat (2009) 1.74
Genomic in situ hybridization to identify alien chromosomes and chromosome segments in wheat. Theor Appl Genet (1992) 1.72
Pathogenesis of Salmonella-mediated intestinal fluid secretion. Activation of adenylate cyclase and inhibition by indomethacin. Gastroenterology (1975) 1.71
Sucrose in oral therapy for cholera and related diarrhoeas. Lancet (1975) 1.69
Rice-based oral rehydration solution decreases the stool volume in acute diarrhoea. Bull World Health Organ (1985) 1.68
Enterotoxigenic Escherichia coli and idiopathic diarrhoea in Bangladesh. Lancet (1975) 1.67
Oral rehydration and maintenance of children with rotavirus and bacterial diarrhoeas. Bull World Health Organ (1979) 1.65
Effect of glycine and glucose on sodium and water adsorption in patients with cholera. Gut (1970) 1.59
Antibiotic therapy of cholera in children. Bull World Health Organ (1967) 1.58
Toxins of Vibrio cholerae and Escherichia coli stimulate adenyl cyclase in rat fat cells. Nature (1974) 1.58
Aspergillosis in four renal transplant recipients. Diagnosis and effective treatment with amphotericin B. Ann Intern Med (1972) 1.58
A highly ceftriaxone-resistant Salmonella typhi in Bangladesh. Pediatr Infect Dis J (1999) 1.57
Stimulation of insulin secretion by infusion of free fatty acids. J Clin Invest (1969) 1.56
Cholera in children. Lancet (1966) 1.56
Multiple aortic thrombi associated with protein C and S deficiency. Mayo Clin Proc (2001) 1.52
Genetic susceptibility to cholera. Ann Hum Biol (1980) 1.44
Low airloss hydrotherapy versus standard care for incontinent hospitalized patients. J Am Geriatr Soc (1998) 1.44
Hand washing with soap reduces diarrhoea and spread of bacterial pathogens in a Bangladesh village. J Diarrhoeal Dis Res (1996) 1.43
Distribution and spread of colonic lesions in shigellosis: a colonoscopic study. J Infect Dis (1984) 1.42
Cholera-like toxic effect of culture filtrates of Escherichia coli. J Infect Dis (1974) 1.40
Temperature-sensitive mutants of influenza A virus: evaluation of the Alaska/77-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers. Arch Virol (1980) 1.39
Evaluating mumps vaccines. Lancet (1992) 1.38
Stimulation of intestinal secretion in vitro by culture filtrates of Escherichia coli. J Infect Dis (1972) 1.36
Characterization by enzyme-linked immunosorbent assay using subgroup- and serotype-specific monoclonal antibodies of human rotavirus obtained from diarrheic patients in Bangladesh. J Clin Microbiol (1989) 1.36
Cholera toxoid boosts serum Escherichia coli antitoxin in humans. Infect Immun (1974) 1.35
A clinical trial of oral therapy in a rural cholera-treatment center. Am J Trop Med Hyg (1970) 1.34
Shiga bacillus dysentery associated with marked leukocytosis and erythrocyte fragmentation. Johns Hopkins Med J (1975) 1.34
Lack of person-to-person transmission of enterotoxigenic Escherichia coli despite close contact. Am J Epidemiol (1980) 1.34
Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J Gastroenterol Hepatol (2005) 1.34
Acetate in the correction of acidosis secondary to diarrhoea. Lancet (1969) 1.31
Stimulation of insulin secretion by long-chain free fatty acids. A direct pancreatic effect. J Clin Invest (1973) 1.30
The relationship of superior mesenteric artery blood flow to gut electrolyte loss in experimental cholera. J Infect Dis (1969) 1.27
Ivermectin for human strongyloidiasis and other intestinal helminths. Am J Trop Med Hyg (1989) 1.27
Campylobacter jejuni diarrhea model in infant chickens. Infect Immun (1984) 1.26
Adenyl cyclase in human platelets: activity and responsiveness. Biochem Biophys Res Commun (1969) 1.26
Distal anterior cerebral artery aneurysms. Surg Neurol (1999) 1.26
Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains causing childhood infections in Bangladesh, 1993 to 1997. J Clin Microbiol (1999) 1.25
Cholera is primarily waterborne in Bangladesh. Lancet (1976) 1.24
An FTO variant is associated with Type 2 diabetes in South Asian populations after accounting for body mass index and waist circumference. Diabet Med (2011) 1.23
Cholera, copepods, and chitinase. Lancet (1976) 1.23
Hypoglycemia in children with acute diarrhoea. Lancet (1966) 1.22
Oral (or nasogastric) maintenance therapy for cholera patients in all age-groups. Bull World Health Organ (1970) 1.22
Astigmatism in Chinese preschool children: prevalence, change, and effect on refractive development. Br J Ophthalmol (2004) 1.22
Faecal carriage of group B streptococci. J Clin Pathol (1980) 1.21
Evaluation of a latex agglutination test for Clostridium difficile in two nursing home outbreaks. J Clin Microbiol (1989) 1.20
Cholera in Africa: a message for the West. Ann Intern Med (1975) 1.19
Diphtheroid endocarditis. Report of nine cases and review of the literature. Johns Hopkins Med J (1976) 1.19
Improving essential obstetric and newborn care in resource-poor countries. J Obstet Gynaecol (2011) 1.18
Hospital costs and mortality attributed to nosocomial bacteremias. JAMA (1978) 1.18
Cholera: combined clinical staff conference at the National Institutes of Health. Ann Intern Med (1966) 1.17
Interpretation of the Widal test in the diagnosis of typhoid fever in Bangladeshi children. Ann Trop Paediatr (1996) 1.16
Prevalence of enamel hypoplasia and isolated opacities in the primary dentition. Pediatr Dent (2001) 1.16
Comparison of sucrose with glucose in oral therapy of infant diarrhoea. Lancet (1978) 1.16
Pancreatic and hepatic hypersecretion in cholera. Lancet (1965) 1.16
Postantibiotic colonization with Clostridium difficile in nursing home patients. J Am Geriatr Soc (1990) 1.14
Oral or nasogastric maintenance therapy for diarrhoea of unknown aetiology resembling cholera. Trans R Soc Trop Med Hyg (1970) 1.13
Chlorpromazine reduces fluid-loss in cholera. Lancet (1979) 1.12
Oral or nasogastric maintenance therapy in pediatric cholera patients. J Pediatr (1971) 1.10
Urodynamic findings in adult females with frequency and dysuria. Br J Urol (1975) 1.09
Progress in oral rehydration therapy. Sci Am (1991) 1.09
Electrolyte transport in human ileum: effect of purified cholera exotoxin. Am J Physiol (1973) 1.08
Food as a vehicle of transmission of cholera. J Diarrhoeal Dis Res (1999) 1.08
Response of the canine duodenum to intraluminal challenge with cholera exotoxin. J Clin Invest (1968) 1.08
Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh. J Health Popul Nutr (2000) 1.08
Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents. Antimicrob Agents Chemother (1987) 1.08
Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years. Pediatr Infect Dis J (1996) 1.07
Anaemia and iron deficiency among adolescent schoolgirls in peri-urban Bangladesh. Eur J Clin Nutr (2000) 1.07
Prospective evaluation of clinical criteria to select older persons with acute medical illness for care in a hypothetical home hospital. J Am Geriatr Soc (1997) 1.07
Response of canine Thiry-Vella jejunal loops to cholera exotoxin and its modification by ethacrynic acid. J Infect Dis (1969) 1.07
Mumps vaccine complications: which strain? Lancet (1989) 1.07
Cholera, non-vibrio cholera, and stomach acid. Lancet (1978) 1.07
Rapid correction of acidosis and dehydration of cholera with oral electrolyte and glucose solution. Lancet (1970) 1.07
microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ. Oncogene (2011) 1.06
The problem of emesis during oral glucose-electrolytes therapy given from the onset of severe cholera. Trans R Soc Trop Med Hyg (1979) 1.06
Epidemiologic and clinical features of invasive amebiasis in Bangladesh: a case-control comparison with other diarrheal diseases and postmortem findings. Am J Trop Med Hyg (1988) 1.06